Development and validation of a nomogram for predicting recurrence risk in pediatric ameloblastoma treated with conservative surgery
- PMID: 41761249
- DOI: 10.1186/s12903-026-07944-0
Development and validation of a nomogram for predicting recurrence risk in pediatric ameloblastoma treated with conservative surgery
Keywords: Ameloblastoma; Conservative surgery; Nomogram; Pediatric.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was approved by the Medical Ethics Committee of the Hospital of Stomatology, Sun Yat-sen University, and the requirement for informed consent was waived by the Medical Ethics Committee of the Hospital of Stomatology, Sun Yat-sen University (Approval No.: KQEC-2025–084-01). The study was conducted in accordance with the Declaration of Helsinki. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
References
-
- Vered M, Wright JM. Update from the 5th edition of the World Health Organization classification of head and neck tumors: odontogenic and maxillofacial bone tumours. Head Neck Pathol. 2022;16(1):63–75.
-
- Chaudhary Z, Krishnan S, Sharma P, Sharma R, Kumar P. A review of literature on ameloblastoma in children and adolescents and a rare case report of ameloblastoma in a 3-year-old child. Craniomaxillofac Trauma Reconstr. 2012;5(3):161–8.
-
- Zhang J, Gu Z, Jiang L, Zhao J, Tian M, Zhou J, et al. Ameloblastoma in children and adolescents. Br J Oral Maxillofac Surg. 2010;48(7):549–54.
-
- Hendra FN, Van Cann EM, Helder MN, Ruslin M, de Visscher JG, Forouzanfar T, et al. Global incidence and profile of ameloblastoma: a systematic review and meta-analysis. Oral Dis. 2020;26(1):12–21.
-
- Effiom OA, Ogundana OM, Akinshipo AO, Akintoye SO. Ameloblastoma: current etiopathological concepts and management. Oral Dis. 2018;24(3):307–16.
Grants and funding
LinkOut - more resources
Full Text Sources
